Singulex Inc - Product Pipeline Analysis, 2018 Update

Singulex Inc - Product Pipeline Analysis, 2018 Update


  • Products Id :- GDME445PD
  • |
  • Pages: 45
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Singulex Inc (Singulex) is a medical device company develops single molecule counting technology. The company provides Sgx clarity system, an in vitro diagnostics platform that provides high sensitivity next generation immunodiagnostics. Its proprietary SMC technology allows scientists and physicians in identifying the biomarkers of disease. Singulex's SMC technology offer ultrasensitive lab testing services for facilitating proactive health management. The company also provides immunoassay kits and reagents and immunoassay systems. It offers services such as clinical lab testing, patient lab testing, wellness programs, clinical laboratory consulting and billing and client services. The company's technology is used for medical practice or clinical diagnostics and scientific research applications. Singulex is headquartered in Alameda, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Singulex Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Singulex Inc Company Overview 6

Singulex Inc Company Snapshot 6

Singulex Inc Pipeline Products and Ongoing Clinical Trials Overview 6

Singulex Inc-Pipeline Analysis Overview 9

Singulex Inc-Key Facts 9

Singulex Inc-Major Products and Services 10

Singulex Inc Pipeline Products by Development Stage 11

Singulex Inc Ongoing Clinical Trials by Trial Status 13

Singulex Inc Pipeline Products Overview 14

Sgx Clarity cTnl Assay 14

Sgx Clarity cTnl Assay Product Overview 14

Sgx Clarity System 15

Sgx Clarity System Product Overview 15

Sgx Clarity System Clinical Trial 16

Sgx Clarity System-Companion Diagnostic Assay 17

Sgx Clarity System-Companion Diagnostic Assay Product Overview 17

Sgx Clarity System-Sepsis Rule-Out / Rule-In Test 18

Sgx Clarity System-Sepsis Rule-Out / Rule-In Test Product Overview 18

Sgx Clarity System-SIRS Rule-Out / Rule-In Test 19

Sgx Clarity System-SIRS Rule-Out / Rule-In Test Product Overview 19

Singulex POC System 20

Singulex POC System Product Overview 20

SMC Adiponectin Test 21

SMC Adiponectin Test Product Overview 21

SMC Endothelin Assay 22

SMC Endothelin Assay Product Overview 22

SMC HDL With Fractionation Assay 23

SMC HDL With Fractionation Assay Product Overview 23

SMC HDL2b Test 24

SMC HDL2b Test Product Overview 24

SMC IL-10 Assay 25

SMC IL-10 Assay Product Overview 25

SMC IL-17A Assay 26

SMC IL-17A Assay Product Overview 26

SMC IL-6 Assay 27

SMC IL-6 Assay Product Overview 27

SMC Leptin Test 28

SMC Leptin Test Product Overview 28

SMC sdLDL Assay 29

SMC sdLDL Assay Product Overview 29

SMC TNF-Alpha Assay 30

SMC TNF-Alpha Assay Product Overview 30

Ultra-Sensitive Clostridium Difficile Toxin A/B Assay 31

Ultra-Sensitive Clostridium Difficile Toxin A/B Assay Product Overview 31

Singulex Inc-Key Competitors 32

Singulex Inc-Key Employees 33

Singulex Inc-Locations And Subsidiaries 34

Head Office 34

Other Locations & Subsidiaries 34

Joint Venture 34

Recent Developments 35

Singulex Inc, Recent Developments 35

Apr 24, 2018: Singulex Clarity C. diff toxins A/B assay in development shown to be ultrasensitive and highly specific compared with currently available testing options 35

Mar 21, 2018: Study shows cardiac troponin measurement using ultra-sensitive Singulex cTnI test can identify the presence and severity of coronary artery disease in stable, symptomatic outpatients 36

Mar 13, 2018: Study adds to understanding about utility of ultra-sensitive cardiac troponin measurement in diagnosing and predicting cardiovascular syndromes 36

Feb 28, 2018: Study shows high-sensitivity cardiac troponin I concentrations is an independent predictor of obstructive coronary artery disease in patients with suspected stable angina 37

Feb 27, 2018: PAXMAN's scalp cooling system available at all the five highest-ranked cancer centres in the USA 38

Nov 01, 2017: Singulex announces 510(k) submission for the first ultra-sensitive cardiac troponin I (cTnI) test using Single Molecule Counting technology 38

Sep 08, 2017: Singulex Receives New, Broad Patent for Digital Detection Of Cardiac Troponin-I Or Cardiac Troponin-T For Coronary Artery Disease Rule-Out 39

Aug 01, 2017: Evaluations of the Analytical Performance of the Singulex Cardiac Troponin I Assay Used on its Single Molecule Counting Technology Platform Demonstrates Ability to Improve Cardiovascular Disease Rule-Out 39

Jun 05, 2017: Ultra-Sensitive C. Difficile Assay In Development By Singulex Demonstrates Potential To Improve Diagnosis In Pilot Studies 40

Jun 01, 2017: First ultra-sensitive cardiac troponin (cTnI) test using Single Molecule Counting technology receives CE Mark 40

Appendix 42

Methodology 42

About GlobalData 45

Contact Us 45

Disclaimer 45

List of Figures

Singulex Inc Pipeline Products by Equipment Type 7

Singulex Inc Pipeline Products by Development Stage 11

Singulex Inc Ongoing Clinical Trials by Trial Status 13

List of Tables

Singulex Inc Pipeline Products and Ongoing Clinical Trials Overview 6

Singulex Inc Pipeline Products by Equipment Type 7

Singulex Inc Pipeline Products by Indication 8

Singulex Inc Ongoing Clinical Trials by Trial Status 8

Singulex Inc, Key Facts 9

Singulex Inc, Major Products and Services 10

Singulex Inc Number of Pipeline Products by Development Stage 11

Singulex Inc Pipeline Products Summary by Development Stage 12

Singulex Inc Ongoing Clinical Trials by Trial Status 13

Singulex Inc Ongoing Clinical Trials Summary 13

Sgx Clarity cTnl Assay-Product Status 14

Sgx Clarity cTnl Assay-Product Description 14

Sgx Clarity System-Product Status 15

Sgx Clarity System-Product Description 15

Sgx Clarity System-Aiming Towards Evidence Based Interpretation of Cardiac Biomarkers in Patients Presenting with Chest Pain (WESTCOR Study) 16

Sgx Clarity System-Companion Diagnostic Assay-Product Status 17

Sgx Clarity System-Companion Diagnostic Assay-Product Description 17

Sgx Clarity System-Sepsis Rule-Out / Rule-In Test-Product Status 18

Sgx Clarity System-Sepsis Rule-Out / Rule-In Test-Product Description 18

Sgx Clarity System-SIRS Rule-Out / Rule-In Test-Product Status 19

Sgx Clarity System-SIRS Rule-Out / Rule-In Test-Product Description 19

Singulex POC System-Product Status 20

Singulex POC System-Product Description 20

SMC Adiponectin Test-Product Status 21

SMC Adiponectin Test-Product Description 21

SMC Endothelin Assay-Product Status 22

SMC Endothelin Assay-Product Description 22

SMC HDL With Fractionation Assay-Product Status 23

SMC HDL With Fractionation Assay-Product Description 23

SMC HDL2b Test-Product Status 24

SMC HDL2b Test-Product Description 24

SMC IL-10 Assay-Product Status 25

SMC IL-10 Assay-Product Description 25

SMC IL-17A Assay-Product Status 26

SMC IL-17A Assay-Product Description 26

SMC IL-6 Assay-Product Status 27

SMC IL-6 Assay-Product Description 27

SMC Leptin Test-Product Status 28

SMC Leptin Test-Product Description 28

SMC sdLDL Assay-Product Status 29

SMC sdLDL Assay-Product Description 29

SMC TNF-Alpha Assay-Product Status 30

SMC TNF-Alpha Assay-Product Description 30

Ultra-Sensitive Clostridium Difficile Toxin A/B Assay-Product Status 31

Ultra-Sensitive Clostridium Difficile Toxin A/B Assay-Product Description 31

Singulex Inc, Key Employees 33

Singulex Inc, Joint Venture 34

Glossary 44

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Celerus Diagnostics Inc

Calbiotech Inc

BioCheck Inc

A/C Diagnostics LLC

Singulex Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license
Single User License
USD 750 INR 51750
Site License
USD 1500 INR 103500
Corporate User License
USD 2250 INR 155250

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com